Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver (Q46213897)

20 December 2017

title

Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver (English)

1 reference

20 December 2017

0 references

8

1 reference

20 December 2017

Vicente Arroyo

11

1 reference

20 December 2017

Pere Ginès

12

1 reference

20 December 2017

Pau Sancho-Bru

Pau Sancho-Bru

3

0 references

Fernando Silva Ramalho

Fernando Ramalho

6

0 references

Leandra N.Z. Ramalho

Leandra N Ramalho

2

0 references

Juan G. Abraldes

Juan G Abraldes

7

0 references

Marlene Dominguez

9

Marlene Dominguez

1 reference

20 December 2017

author name string

Montserrat Moreno

1

1 reference

20 December 2017

Marta Ruiz-Ortega

4

1 reference

20 December 2017

Marta Ruiz-Ortega

5

1 reference

20 December 2017

Jesús Egido

10

1 reference

20 December 2017

Ramón Bataller

13

1 reference

20 December 2017

publication date

4 December 2008

1 reference

20 December 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

published in

1 reference

20 December 2017

volume

296

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

G147-56

1 reference

20 December 2017

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

1 reference

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Liver fibrogenesis: a new role for the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Isoprenoids as mediators of the biological effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Pitavastatin enhances the anti-fibrogenesis effects of candesartan, an angiotensin II receptor blocker, on CCl4-induced liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Cellular antioxidant effects of atorvastatin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00462.2007

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00462.2007

1 reference

20 December 2017

PubMed ID

19056767

1 reference

20 December 2017